BACKGROUND: Earlier work identified specific tumor-promoting abnormalities that are shared between lung cancers and adjacent normal bronchial epithelia. We sought to characterize the yet unknown global molecular and adjacent airway field cancerization (FC) in early-stage non-small cell lung cancer (NSCLC). METHODS: Whole-transcriptome expression profiling of resected early-stage (I-IIIA) NSCLC specimens (n = 20) with matched tumors, multiple cytologically controlled normal airways with varying distances from tumors, and uninvolved normal lung tissues (n = 194 samples) was performed using the Affymetrix Human Gene 1.0 ST platform. Mixed-effects models were used to identify differentially expressed genes among groups. Ordinal regression analysis was performed to characterize site-dependent airway expression profiles. All statistical tests were two-sided, except where noted. RESULTS: We identified differentially expressed gene features (n = 1661) between NSCLCs and airways compared with normal lung tissues, a subset of which (n = 299), after gene set enrichment analysis, statistically significantly (P < .001) distinguished large airways in lung cancer patients from airways in cancer-free smokers. In addition, we identified genes (n = 422) statistically significantly and progressively differentially expressed in airways by distance from tumors that were found to be congruently modulated between NSCLCs and normal lung tissues. Furthermore, LAPTM4B, with statistically significantly increased expression (P < .05) in airways with shorter distance from tumors, was upregulated in human immortalized cells compared with normal bronchial epithelial cells (P < .001) and promoted anchorage-dependent and -independent lung cancer cell growth. CONCLUSIONS: The adjacent airway FC comprises both site-independent profiles as well as gradient and localized airway expression patterns. Profiling of the airway FC may provide new insights into NSCLC oncogenesis and molecular tools for detection of the disease.
BACKGROUND: Earlier work identified specific tumor-promoting abnormalities that are shared between lung cancers and adjacent normal bronchial epithelia. We sought to characterize the yet unknown global molecular and adjacent airway field cancerization (FC) in early-stage non-small cell lung cancer (NSCLC). METHODS: Whole-transcriptome expression profiling of resected early-stage (I-IIIA) NSCLC specimens (n = 20) with matched tumors, multiple cytologically controlled normal airways with varying distances from tumors, and uninvolved normal lung tissues (n = 194 samples) was performed using the Affymetrix Human Gene 1.0 ST platform. Mixed-effects models were used to identify differentially expressed genes among groups. Ordinal regression analysis was performed to characterize site-dependent airway expression profiles. All statistical tests were two-sided, except where noted. RESULTS: We identified differentially expressed gene features (n = 1661) between NSCLCs and airways compared with normal lung tissues, a subset of which (n = 299), after gene set enrichment analysis, statistically significantly (P < .001) distinguished large airways in lung cancerpatients from airways in cancer-free smokers. In addition, we identified genes (n = 422) statistically significantly and progressively differentially expressed in airways by distance from tumors that were found to be congruently modulated between NSCLCs and normal lung tissues. Furthermore, LAPTM4B, with statistically significantly increased expression (P < .05) in airways with shorter distance from tumors, was upregulated in human immortalized cells compared with normal bronchial epithelial cells (P < .001) and promoted anchorage-dependent and -independent lung cancer cell growth. CONCLUSIONS: The adjacent airway FC comprises both site-independent profiles as well as gradient and localized airway expression patterns. Profiling of the airway FC may provide new insights into NSCLC oncogenesis and molecular tools for detection of the disease.
Authors: Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff Journal: Cancer Res Date: 2003-04-15 Impact factor: 12.701
Authors: Steven A Belinsky; William A Palmisano; Frank D Gilliland; Lida A Crooks; Kevin K Divine; Sally A Winters; Marcie J Grimes; Heidi J Harms; Carmen S Tellez; Tammy M Smith; Pam P Moots; John F Lechner; Christine A Stidley; Richard E Crowell Journal: Cancer Res Date: 2002-04-15 Impact factor: 12.701
Authors: I I Wistuba; C Behrens; A K Virmani; G Mele; S Milchgrub; L Girard; J W Fondon; H R Garner; B McKay; F Latif; M I Lerman; S Lam; A F Gazdar; J D Minna Journal: Cancer Res Date: 2000-04-01 Impact factor: 12.701
Authors: Avrum Spira; Jennifer Beane; Vishal Shah; Gang Liu; Frank Schembri; Xuemei Yang; John Palma; Jerome S Brody Journal: Proc Natl Acad Sci U S A Date: 2004-06-21 Impact factor: 11.205
Authors: Humam Kadara; Smruthy Sivakumar; Yasminka Jakubek; F Anthony San Lucas; Wenhua Lang; Tina McDowell; Zachary Weber; Carmen Behrens; Gareth E Davies; Neda Kalhor; Cesar Moran; Randa El-Zein; Reza Mehran; Stephen G Swisher; Jing Wang; Jianjun Zhang; Junya Fujimoto; Jerry Fowler; John V Heymach; Steven Dubinett; Avrum E Spira; Erik A Ehli; Ignacio I Wistuba; Paul Scheet Journal: Am J Respir Crit Care Med Date: 2019-09-15 Impact factor: 21.405
Authors: Yu-An Zhang; Xiaotu Ma; Adwait Sathe; Junya Fujimoto; Ignacio Wistuba; Stephen Lam; Yasushi Yatabe; Yi-Wei Wang; Victor Stastny; Boning Gao; Jill E Larsen; Luc Girard; Xiaoyun Liu; Kai Song; Carmen Behrens; Neda Kalhor; Yang Xie; Michael Q Zhang; John D Minna; Adi F Gazdar Journal: J Thorac Oncol Date: 2015-12-25 Impact factor: 15.609
Authors: Ivana V Yang; Brent S Pedersen; Einat Rabinovich; Corinne E Hennessy; Elizabeth J Davidson; Elissa Murphy; Brenda Juan Guardela; John R Tedrow; Yingze Zhang; Mandal K Singh; Mick Correll; Marvin I Schwarz; Mark Geraci; Frank C Sciurba; John Quackenbush; Avrum Spira; Naftali Kaminski; David A Schwartz Journal: Am J Respir Crit Care Med Date: 2014-12-01 Impact factor: 21.405
Authors: Irina G Luzina; Mariah V Salcedo; Mónica L Rojas-Peña; Anne E Wyman; Jeffrey R Galvin; Ashutosh Sachdeva; Andrew Clerman; June Kim; Teri J Franks; Edward J Britt; Jeffrey D Hasday; Si M Pham; Allen P Burke; Nevins W Todd; Sergei P Atamas Journal: Cell Immunol Date: 2018-01-03 Impact factor: 4.868
Authors: Junya Fujimoto; Sayuri Nunomura-Nakamura; Yihua Liu; Wenhua Lang; Tina McDowell; Yasminka Jakubek; Dalia Ezzeddine; Joshua Kapere Ochieng; Jason Petersen; Gareth Davies; Junya Fukuoka; Ignacio I Wistuba; Erik Ehli; Jerry Fowler; Paul Scheet; Humam Kadara Journal: Int J Cancer Date: 2017-07-17 Impact factor: 7.396
Authors: Joseph Ambrose; Michelle Livitz; Deborah Wessels; Spencer Kuhl; Daniel F Lusche; Amanda Scherer; Edward Voss; David R Soll Journal: Am J Cancer Res Date: 2015-10-15 Impact factor: 6.166